Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells-Reference-Cited by-同舟云学术

Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells

Published:2018-07-11 Issue: Volume: Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Satta Alessandro¹,Mezzanzanica Delia¹^ORCID,Caroli Francesco¹,Frigerio Barbara¹^ORCID,Nicola Massimo Di²³,Kontermann Roland E.⁴^ORCID,Iacovelli Federico⁵^ORCID,Desideri Alessandro⁵,Anichini Andrea⁶,Canevari Silvana¹^ORCID,Gianni Alessandro Massimo²³,Figini Mariangela¹^ORCID

Affiliation:

1. Molecular Therapies Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Medical Oncology C Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. University of Milan, Milan, Italy

4. Institut für Zellbiologie und Immunologie, Universität Stuttgart, Stuttgart, Germany

5. Department of Biology, University of Rome Tor Vergata, Rome, Italy

6. Human Tumor Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Funder

AIRC

AIRC 5 × 1000

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2018.1494105

Reference49 articles.

1. Identification and characterization of a new member of the TNF family that induces apoptosis

2. Targeting death and decoy receptors of the tumour-necrosis factor superfamily